Chemiluminescent Immunoassay Development

Chemiluminescent Immunoassays (CLIAs) have revolutionized biological and chemical detection. Based on the detection of a protein that glows or emits light in a chemiluminescent reaction, CLIA is a faster assays technique that does not require stop reactions and has short incubation times. In addition, it has a much wider detection range than either RIAs or ELISAs and is also extremely sensitive under low analyte concentration conditions.

CDSimple™ Chemiluminescent ELISA platform offers a seamless process through which we will develop high-quality assays for your application. Depending on your need, assays may be developed for basic research purposes or designed to include additional qualification and validation.

Key Benefits

  • Antibody matched pair screening experience
  • Extensive assay development experience
  • Facilitate the transition from RUO to IVD
  • Personalized assay development and support every step of the way

Chemiluminescent Immunoassay Development


Creative Diagnostics will carry out the approval proposal and deliver the expected results and documents in a time and cost effective manner. Our staff scientists follow rigorous guidelines for quality control with a focus on thorough optimization and validation of every aspect of assay development, including antibody specificity, assay sensitivity, reproducibility (intra- and inter-assay), cross-reactivity, standard curve range, assay accuracy (linearity and recovery) and kit stability.

Online Inquiry

Phone: *
E-mail Address: *
Service & Products Interested: *
Project Description:
Verification Code: * Please input "diagnostics" as verification code.


Creative Diagnostics provides the highest quality products and services.

Inquiry Basket